439 related articles for article (PubMed ID: 9794926)
1. Functional analysis of HBV genomes from patients with fulminant hepatitis.
Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
3. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
4. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.
Scaglioni PP; Melegari M; Wands JR
Virology; 1997 Jul; 233(2):374-81. PubMed ID: 9217060
[TBL] [Abstract][Full Text] [Related]
5. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene.
Günther S; Piwon N; Jung A; Iwanska A; Schmitz H; Will H
Virology; 2000 Aug; 273(2):286-99. PubMed ID: 10915599
[TBL] [Abstract][Full Text] [Related]
6. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
[TBL] [Abstract][Full Text] [Related]
7. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of hepatitis B virus genomes from an infant with acute severe hepatitis and a hepatitis B e antigen-positive carrier mother.
Komatsu H; Inui A; Morinishi Y; Sogo T; Fujisawa T
J Med Virol; 2001 Nov; 65(3):457-62. PubMed ID: 11596078
[TBL] [Abstract][Full Text] [Related]
9. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
[TBL] [Abstract][Full Text] [Related]
10. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
Kim HJ; Yoo BC
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
[TBL] [Abstract][Full Text] [Related]
11. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion.
Chan HL; Hussain M; Lok AS
Hepatology; 1999 Mar; 29(3):976-84. PubMed ID: 10051506
[TBL] [Abstract][Full Text] [Related]
12. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
[TBL] [Abstract][Full Text] [Related]
13. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis.
Kalinina T; Riu A; Fischer L; Will H; Sterneck M
Hepatology; 2001 Aug; 34(2):385-94. PubMed ID: 11481624
[TBL] [Abstract][Full Text] [Related]
14. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis.
Pollicino T; Zanetti AR; Cacciola I; Petit MA; Smedile A; Campo S; Sagliocca L; Pasquali M; Tanzi E; Longo G; Raimondo G
Hepatology; 1997 Aug; 26(2):495-9. PubMed ID: 9252165
[TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis.
Märschenz S; Endres AS; Brinckmann A; Heise T; Kristiansen G; Nürnberg P; Krüger DH; Günther S; Meisel H
Gastroenterology; 2006 Sep; 131(3):765-80. PubMed ID: 16952546
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation.
Sterneck M; Günther S; Santantonio T; Fischer L; Broelsch CE; Greten H; Will H
Hepatology; 1996 Aug; 24(2):300-6. PubMed ID: 8690396
[TBL] [Abstract][Full Text] [Related]
18. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.
Moriyama K; Okamoto H; Tsuda F; Mayumi M
Virology; 1996 Dec; 226(2):269-80. PubMed ID: 8955047
[TBL] [Abstract][Full Text] [Related]
19. Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B.
Wu W; Chen Y; Ruan B; Li LJ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):530-4. PubMed ID: 16286257
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
